Linea guida per la terapia dei prolattinomi
Author:
Publisher
Springer Science and Business Media LLC
Subject
Microbiology
Link
https://link.springer.com/content/pdf/10.1007/s40619-023-01327-1.pdf
Reference76 articles.
1. Chanson P, Maiter D (2019) The epidemiology, diagnosis and treatment of prolactinomas: the old and the new. Best Pract Res Clin Endocrinol Metab 33:101290
2. Vroonen L, Daly AF, Beckers A (2019) Epidemiology and management challenges in prolactinomas. Neuroendocrinology 109:20–27
3. Olarescu NC, Perez-Rivas LG, Gatto F et al. on behalf of EYRC (ENEA Young Researcher Committee) (2019) Aggressive and malignant prolactinomas. Neuroendocrinology 109:57–69
4. De Laat JM, Dekkers OM, Pieterman CR et al. (2015) Long-term natural course of pituitary tumors in patients with MEN1: results from the Dutch MEN1 study group (DMSG). J Clin Endocrinol Metab 100:3288–3296
5. Daly AF, Tichomirowa MA, Petrossians P et al. (2010) Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study. J Clin Endocrinol Metab 95:E373–383
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3